NCT04766983View on ClinicalTrials.gov

Incidence of VAP in Patients With Severe COVID-19

CompletedOBSERVATIONAL
Enrollment

323

Participants

Timeline

Start Date

February 28, 2020

Primary Completion Date

May 31, 2022

Study Completion Date

January 31, 2023

Conditions
Ventilator Associated PneumoniaCovid19
Interventions
DIAGNOSTIC_TEST

bronchoalveolar lavage

BAL and ETA are performed as per clinical practice on clinical suspicion of VAP (Johanson score)

Trial Locations (1)

20122

IRCCS Ca' Granda Ospedale Maggiore Policlinico Foundation, Milan

All Listed Sponsors
lead

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

OTHER

NCT04766983 - Incidence of VAP in Patients With Severe COVID-19 | Biotech Hunter | Biotech Hunter